Acute HCV in HIV-Infected MSM: Modes of Acquisition, Liver Fibrosis, and Treatment

Current HIV/AIDS Reports

Volumn 12, Issue 3, 2015, Pages 317-325

  Kaplan Lewis, Emma ^a   Fierer, Daniel Seth ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Acute hepatitis C (HCV) infection; Direct acting antivirals (DAA); HIV AIDS; Liver fibrosis; Men who have sex with men (MSM); Sexual transmission

Indexed keywords

ALANINE AMINOTRANSFERASE; BOCEPREVIR; HEPATITIS C ANTIBODY; LEDIPASVIR; PEGINTERFERON; RIBAVIRIN; SOFOSBUVIR; TELAPREVIR; ANTIVIRUS AGENT;

ACUTE HEPATITIS C; ANAL DOUCHING; ANAL INTERCOURSE; ANTIBODY SCREENING; ANUS INJURY; CD4 LYMPHOCYTE COUNT; COMBINATION CHEMOTHERAPY; DISEASE SURVEILLANCE; DRUG EFFICACY; DRUG TOLERABILITY; FISTING; GASTROENTEROLOGICAL PROCEDURE; GROUP SEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INFECTION RATE; INFECTION RISK; LIVER FIBROSIS; MALE; MEN WHO HAVE SEX WITH MEN; NONHUMAN; RECTUM HEMORRHAGE; REVIEW; RISK FACTOR; SEROCONVERSION; SEXUAL PRACTICE; SEXUALLY TRANSMITTED DISEASE; UNPROTECTED SEX; VIRUS LOAD; VIRUS TRANSMISSION; ACUTE DISEASE; COMPLICATION; DISEASE COURSE; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CIRRHOSIS; MALE HOMOSEXUALITY; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES, VIRAL; TRANSMISSION;

ACUTE DISEASE; ANTIVIRAL AGENTS; DISEASE PROGRESSION; HEPATITIS C; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; LIVER CIRRHOSIS; MALE; RISK FACTORS; RISK-TAKING; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES, VIRAL;

EID: 84938969578     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-015-0279-3     Document Type: Review

References (62)

1. Tohme RA, Holmberg SD. Is sexual contact a major mode of hepatitis C virus transmission? Hepatology. 2010;52(4):1497–505.
2. Gilleece YC, Browne RE, Asboe D, Atkins M, Mandalia S, Bower M, et al. Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirin. J Acquir Immune Defic Syndr. 2005;40(1):41–6.
3. Ghosn J, Pierre-François S, Thibault V, Duvivier C, Tubiana R, Simon A, et al. Acute hepatitis C in HIV-infected men who have sex with men. HIV Med. 2004;5(4):303–6.
4. Bottieau E, Apers L, Van Esbroeck M, Vandenbruaene M, Florence E. Hepatitis C virus infection in HIV-infected men who have sex with men: sustained rising incidence in Antwerp, Belgium, 2001–2009. Euro Surveill. 2010;15(39):19673.
5. Van de Laar T, Pybus O, Bruisten S, Brown D, Nelson M, Bhagani S, et al. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology. 2009;136(5):1609–17.
6. Vogel M. Epidemiology and treatment of sexually transmitted acute hepatitis C. Curr Opin HIV AIDS. 2007;2(6):454–9.
7. Matthews GV, Hellard M, Haber P, Yeung B, Marks P, Baker D, et al. Characteristics and treatment outcomes among HIV-infected individuals in the Australian trial in acute hepatitis C. Clin Infect Dis. 2009;48(5):650–8.
8. Luetkemeyer A, Hare CB, Stansell J, Tien PC, Charlesbois E, Lum P, et al. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. J Acquir Immune Defic Syndr. 2006;41(1):31–6.
9. Fierer DS, Uriel AJ, Carriero DC, Klepper A, Dieterich DT, Mullen MP, et al. Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study. J Infect Dis. 2008;198(5):683–6.
10. Heller T, Rehermann B. Acute hepatitis C: a multifaceted disease. Semin Liver Dis. 2005;25(1):7–17.
11. Glynn SA, Wright DJ, Kleinman SH, Hirschkorn D, Tu Y, Heldebrant C, et al. Dynamics of viremia in early hepatitis C virus infection. Transfusion (Paris). 2005;45(6):994–1002.
12. Thomson EC, Nastouli E, Main J, Karayiannis P, Eliahoo J, Muir D, et al. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS Lond Engl. 2009;23(1):89–93.
13. Vanhommerig JW, Thomas XV, van der Meer JTM, Geskus RB, Bruisten SM, Molenkamp R. Hepatitis C virus (HCV) antibody dynamics following acute HCV infection and reinfection among HIV-infected men who have sex with men. Clin Infect Dis. 2014;59(12):1678–85. Demonstrated median time to HCV antibody seroconversion of 74 days in HIV-infected MSM, somewhat longer than expected in HIV-uninfected men. This study was the first to demonstrate sero-reversion amongst a high proportion those cured by interferon treatment.
14. Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:3.
15. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137(1):1–10.
16. Fierer DS. Epidemic of sexually transmitted hepatitis C virus infection among HIV-infected men. Curr Infect Dis Rep. 2010;12(2):118–25.
17. Vogel M, Deterding K, Wiegand J, Grüner NH, Baumgarten A, Jung MC, et al. Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals—experience from 2 large German networks on the study of acute HCV infection. Clin Infect Dis. 2009;49(2):317–9. author reply 319.
18. Vanhommerig JW, van de Laar TJW, Koot M, van Rooijen MS, Schinkel J, Speksnijder AGCL, et al. Evaluation of a hepatitis C virus (HCV) antigen assay for routine HCV screening among men who have sex with men infected with HIV. J Virol Methods. 2015;213:147–50.
19. Urbanus AT, van de Laar TJ, Stolte IG, Schinkel J, Heijman T, Coutinho RA, et al. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS Lond Engl. 2009;23(12):F1–7.
20. Wandeler G, Gsponer T, Bregenzer A, Günthard HF, Clerc O, Calmy A, et al. Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic. Clin Infect Dis. 2012;55(10):1408–16.
21. Sun H-Y, Chang S-Y, Yang Z-Y, Lu C-L, Wu H, Yeh C-C, et al. Recent hepatitis C virus infections in HIV-infected patients in Taiwan: incidence and risk factors. J Clin Microbiol. 2012;50(3):781–7.
22. Nishijima T, Shimbo T, Komatsu H, Hamada Y, Gatanaga H, Oka S. Incidence and risk factors for incident hepatitis C infection among men who have sex with men with HIV-1 infection in a large urban HIV clinic in Tokyo. J Acquir Immune Defic Syndr. 2014;65(2):213–7.
23. Ishikani M, Watanabe K, Tsukada K, Nozaki Y, Yanase M, Igari T, et al. Acute hepatitis C in HIV-1 infected Japanese cohort: single center retrospective cohort study. PLoS One. 2014;9(6).
24. Urbanus AT, Van De Laar TJW, Geskus R, Vanhommerig JW, Van Rooijen MS, Schinkel J, et al. Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995–2010. AIDS Lond Engl. 2014;28(5):781–90. Demonstrated an almost four-fold increase in HCV incidence among MSM in Amsterdam and described associated risk factors including fisting.
25. Vanhommerig JW, Stolte IG, Lambers FAE, Geskus RB, van de Laar TJW, Bruisten SM, et al. Stabilizing incidence of hepatitis C virus infection among men who have sex with men in Amsterdam. J Acquir Immune Defic Syndr. 2014;66(5):e111–5. Showed a plateau in rates of HCV seroconversion among HIV-infected MSM beginning in about 2005 in the Amsterdam cohort, although calculations didn't account for reinfections of men who remained seropositive after cure.
26. Lambers FAE, Prins M, Thomas X, Molenkamp R, Kwa D, Brinkman K, et al. Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM. AIDS Lond Engl. 2011;25(17):F21–7.
27. Fierer DS, Dieterich DT, Mullen MP, Branch AD, Uriel AJ, Carriero DC, et al. Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men. Clin Infect Dis. 2014;58(6):873–9. The first study to use DAA in acute HCV, demonstrated SVR12 rates of 84% with just 12-week course telaprevir + peg-IFN + RBV, compared to 63% treated with peg-IFN + RBV for 24+ weeks.
28. Ingiliz P, Krznaric I, Stellbrink H-J, Knecht G, Lutz T, Noah C, et al. Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance. HIV Med. 2014;15(6):355–61. The large experience from this cohort in Berlin provides sobering evidence of continued behaviors associated with reinfection even after interferon treatment.
29. Ristig MB, Tebas P, Gandy I, Qaqish R, Aberg JA. Cure of acute hepatitis C in HIV co-infection? J Clin Gastroenterol. 2004;38(3):303.
30. Centers for Disease Control and Prevention (CDC). Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men—New York City, 2005–2010. MMWR Morb Mortal Wkly Rep. 2011;60(28):945–50.
31. Garg S, Taylor LE, Grasso C, Mayer KH. Prevalent and incident hepatitis C virus infection among HIV-infected men who have sex with men engaged in primary care in a Boston community health center. Clin Infect Dis. 2013;56(10):1480–7.
32. Taylor LE, Foont JA, DeLong AK, Wurcel A, Linas BP, Chapman S, et al. The spectrum of undiagnosed hepatitis C virus infection in a US HIV clinic. AIDS Patient Care STDS. 2014;28(1):4–9. Showed the low rate of consistent screening for HCV among high-risk patients even at an academic medical center.
33. Taylor LE, Holubar M, Wu K, Bosch RJ, Wyles DL, Davis JA, et al. Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials. Clin Infect Dis. 2011;52(6):812–8.
34. Witt MD, Seaberg EC, Darilay A, Young S, Badri S, Rinaldo CR, et al. Clin Infect Dis. 2013;57(1):77–84. A large cohort study in the US showing a stable incidence of HCV in MSM over 17 years, although not in the cities earliest/hardest hit in the epidemic.
35. Breskin A, Drobnik A, Pathela P, Chan C, Braunstein S, Bornschlegel K, et al. Factors associated with hepatitis C infection among HIV-infected men who have sex with men with no reported injection drug use in New York City, 2000–2010. In Press; First and very large population study of this epidemic, finding over 2,000 incident cases of HCV infection in HIV-infected MSM in NYC. Incident syphilis was significantly associated with subsequent HCV. Hispanics and blacks were disproportionately affected compared to whites.
36. Fierer DS, Factor S. Defining the scope of sexually transmitted HCV epidemic among HIV-infeced men who have sex with men in NYC. Sex Transm Dis. In Press.
37. Danta M, Brown D, Bhagani S, Pybus OG, Sabin CA, Nelson M, et al. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS Lond Engl. 2007;21(8):983–91.
38. Schmidt AJ, Rockstroh JK, Vogel M, An der Heiden M, Baillot A, Krznaric I. Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany—a case-control study. PLoS One. 2011;6(3):e17781.
39. Apers L, Vanden Berghe W, De Wit S, Kabeya K, Callens S, Buyze J, et al. Risk factors for HCV acquisition among HIV-positive MSM in Belgium. J Acquir Immune Defic Syndr. 2015;68(5):585–93. Case control study which demonstrated for the first time that douching is a risk for sexual transmission of HCV.
40. Luo L, Reilly KH, Xu JJ, Wang GX, Ding GW, Wang N, Wang HB. Prevalence and correlates of Trichomonas vaginalis infection among female sex workers in a city of Yunnan Province, China. Int J STD AIDS. 2015 May 7.
41. Annang L, Grimley DM, Hook EW. Vaginal douche practices among black women at risk: exploring douching prevalence, reasons for douching, and sexually transmitted disease infection. Sex Transm Dis. 2006;33(4):215–9.
42. Blackwell CW. Serosorting sexual partners by gay and bisexual men to prevent HIV infection: implications for public health clinicians. Public Health Nurs Boston Mass. 2015 Feb 6.
43. Volk JE, Marcus JL, Phengrasamy T, Hare CB. Incident hepatitis C Virus infections among users of HIV preexposure prophylaxis in a clinical practice setting. Clin Infect Dis 2015 Feb 18. Worrisome as the possible harbinger of the epidemic expanding into HIV-uninfected MSM, an unintended consequence to one of the most important advances in HIV prevention in the last decade.
44. Leruez-Ville M, Kunstmann JM, De Almeida M, Rouzioux C, Chaix ML. Detection of hepatitis C virus in the semen of infected men. Lancet. 2000;356(9223):42–3.
45. Pasquier C, Daudin M, Righi L, Berges L, Thauvin L, Berrebi A, et al. Sperm washing and virus nucleic acid detection to reduce HIV and hepatitis C virus transmission in serodiscordant couples wishing to have children. AIDS Lond Engl. 2000;14(14):2093–9.
46. Briat A, Dulioust E, Galimand J, Fontaine H, Chaix M-L, Letur-Könirsch H, et al. Hepatitis C virus in the semen of men coinfected with HIV-1: prevalence and origin. AIDS Lond Engl. 2005;19(16):1827–35.
47. Bradshaw D, Lamoury F, Catlett B, Applegate TL, Mcallister J, Dore GJ, et al. A comparison of seminal hepatitis C virus (HCV) RNA levels during recent and chronic HCV infection in HIV-infected and HIV-uninfected individuals. J Infect Dis. 2015;211(5):736–43. The first study to exam seminal HCV in men with acute/recent HCV infection. Seminal VL was actually lower during acute HCV, correlating with overall lower serum HCV during acute HCV in these men.
48. Kouyos RD, Rauch A, Braun DL, Yang W-L, Böni J, Yerly S, et al. Higher risk of incident hepatitis C virus coinfection among men who have sex with men, in whom the HIV genetic bottleneck at transmission was wide. J Infect Dis. 2014;210(10):1555–61. An elegantly conceived study using molecular virological techniques developed to examine HIV transmission and extrapolating to HCV transmission. The results suggested that HIV-infected MSM who participated more vigorously in sex at the time they acquired HIV were more likely to subsequently become HCV infected than those who had not.
49. Cooper F, Barber T. “Gay bowel syndrome”: relic or real (and returning) phenomenon? Curr Opin Infect Dis. 2014;27(1):84–9.
50. Heiman KE, Karlsson M, Grass J, Howie B, Kirkcaldy RD, Mahon B, et al. Notes from the field: Shigella with decreased susceptibility to azithromycin among men who have sex with men—United States, 2002–2013. MMWR Morb Mortal Wkly Rep. 2014;63(6):132–3.
51. Morgan O, Crook P, Cheasty T, Jiggle B, Giraudon I, Hughes H, et al. Shigella sonnei outbreak among homosexual men. Emerg Infect Dis. 2006;12(9):1458–60.
52. Di Benedetto MA, Di Piazza F, Amodio E, Taormina S, Romano N, Firenze A. Prevalence of sexually transmitted infections and enteric protozoa among homosexual men in western Sicily (south Italy). Prev Med Hyg. 2012;53(4):181–5.
53. De Vries HJC, van der Bij AK, Fennema JSA, Smit C, de Wolf F, Prins M, et al. Lymphogranuloma venereum proctitis in men who have sex with men is associated with anal enema use and high-risk behavior. Sex Transm Dis. 2008;35(2):203–8.
54. Fierer DS, Mullen MP, Dieterich DT, Isabel Fiel M, Branch AD. Early-onset liver fibrosis due to primary hepatitis C virus infection is higher over time in HIV-infected men. Clin Infect Dis. 2012;55(6):887–8.
55. Fierer DS, Dieterich DT, Fiel MI, Branch AD, Marks KM, Fusco DN, et al. Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection. Clin Infect Dis. 2013;56(7):1038–43.
56. Vogel M, Page E, Boesecke C, Reiberger T, Schwarze-Zander C, Mauss S, et al. Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individuals. Clin Infect Dis. 2012;54(4):556–9.
57. Lambers FAE, Brinkman K, Schinkel J, Spijkerman IJB, Molenkamp R, Coutinho RA, et al. Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration. AIDS Lond Engl. 2011;25(10):1333–6.
58. Franco S, Tural C, Nevot M, Moltó J, Rockstroh JK, Clotet B, et al. Detection of a sexually transmitted hepatitis C virus protease inhibitor-resistance variant in a human immunodeficiency virus-infected homosexual man. Gastroenterology. 2014;147(3):599–601. This report is the first evidence of what many of us were worried would happen, parallel to the situation in HIV infection, that treatment-induced resistance in HCV is of sufficient representation in the swarm of transmitting virus and is fit enough to be transmitted during sex.
59. European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2014. J Hepatol. 2014;61(2):373–95.
60. HCV guidelines management of acute HCV infection [Internet]. [cited 2015 Mar 29]. Available from: http://www.hcvguidelines.org/full-report/management-acute-hcv-infection.
61. Deterding K, Grüner N, Buggisch P, Wiegand J, Galle PR, Spengler U, et al. Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial. Lancet Infect Dis. 2013;13(6):497–506.
62. Kamal SM, Moustafa KN, Chen J, Fehr J, Abdel Moneim A, Khalifa KE, et al. Duration of peg interferon therapy in acute hepatitis C: a randomized trial. Hepatolog y. 2006;43(5):923–31.